Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 2 June 1995:
Vol. 268. no. 5215, pp. 1350 - 1353
DOI: 10.1126/science.7761854

Articles

Science, Vol 268, Issue 5215, 1350-1353
Copyright © 1995 by American Association for the Advancement of Science


articles

Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor

WJ Koch, HA Rockman, P Samama, RA Hamilton, RA Bond, CA Milano, and RJ Lefkowitz

Howard Hughes Medical Institute, Duke University Medical Center, Durham, NC 27710, USA.

Transgenic mice were created with cardiac-specific overexpression of the beta-adrenergic receptor kinase-1 (beta ARK1) or a beta ARK inhibitor. Animals overexpressing beta ARK1 demonstrated attenuation of isoproterenol-stimulated left ventricular contractility in vivo, dampening of myocardial adenylyl cyclase activity, and reduced functional coupling of beta-adrenergic receptors. Conversely, mice expressing the beta ARK inhibitor displayed enhanced cardiac contractility in vivo with or without isoproterenol. These animals demonstrate the important role of beta ARK in modulating in vivo myocardial function. Because increased amounts of beta ARK1 and diminished cardiac beta-adrenergic responsiveness characterize heart failure, these animals may provide experimental models to study the role of beta ARK in heart disease.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Gene Therapy in Heart Failure.
L. E. Vinge, P. W. Raake, and W. J. Koch (2008)
Circ. Res. 102, 1458-1470
   Abstract »    Full Text »    PDF »
Exercise promotes angiogenesis and improves {beta}-adrenergic receptor signalling in the post-ischaemic failing rat heart.
D. Leosco, G. Rengo, G. Iaccarino, L. Golino, M. Marchese, F. Fortunato, C. Zincarelli, E. Sanzari, M. Ciccarelli, G. Galasso, et al. (2008)
Cardiovasc Res 78, 385-394
   Abstract »    Full Text »    PDF »
Cardiac-restricted Expression of the Carboxyl-terminal Fragment of GRK3 Uncovers Distinct Functions of GRK3 in Regulation of Cardiac Contractility and Growth: GRK3 CONTROLS CARDIAC {alpha}1-ADRENERGIC RECEPTOR RESPONSIVENESS.
L. E. Vinge, T. G. von Lueder, E. Aasum, E. Qvigstad, J. A. Gravning, O.-J. How, T. Edvardsen, R. Bjornerheim, M. S. Ahmed, B. W. Mikkelsen, et al. (2008)
J. Biol. Chem. 283, 10601-10610
   Abstract »    Full Text »    PDF »
Acute beta-blockade prevents myocardial beta-adrenergic receptor desensitization and preserves early ventricular function after brain death..
P. K. Pandalai, K. M. McLean, C. F. Bulcao, J. Y. Duffy, K. M. D'Souza, W. H. Merrill, J. M. Pearl, and S. A. Akhter (2008)
J. Thorac. Cardiovasc. Surg. 135, 792-798
   Abstract »    Full Text »    PDF »
Endocytosis machinery is required for {beta}1-adrenergic receptor-induced hypertrophy in neonatal rat cardiac myocytes.
C. Morisco, C. Marrone, J. Galeotti, D. Shao, D. E. Vatner, S. F. Vatner, and J. Sadoshima (2008)
Cardiovasc Res 78, 36-44
   Abstract »    Full Text »    PDF »
An RNA molecule that specifically inhibits G-protein-coupled receptor kinase 2 in vitro.
G. Mayer, B. Wulffen, C. Huber, J. Brockmann, B. Flicke, L. Neumann, D. Hafenbradl, B. M. Klebl, M. J. Lohse, C. Krasel, et al. (2008)
RNA 14, 524-534
   Abstract »    Full Text »    PDF »
Enhanced calcium cycling and contractile function in transgenic hearts expressing constitutively active G{alpha}o* protein.
M. Zhu, A. A. Gach, G. Liu, X. Xu, C. C. Lim, J. X. Zhang, L. Mao, K. Chuprun, W. J. Koch, R. Liao, et al. (2008)
Am J Physiol Heart Circ Physiol 294, H1335-H1347
   Abstract »    Full Text »    PDF »
Norepinephrine- and Epinephrine-induced Distinct 2-Adrenoceptor Signaling Is Dictated by GRK2 Phosphorylation in Cardiomyocytes.
Y. Wang, V. De Arcangelis, X. Gao, B. Ramani, Y.-s. Jung, and Y. Xiang (2008)
J. Biol. Chem. 283, 1799-1807
   Abstract »    Full Text »    PDF »
Epinephrine-induced activation of LW-mediated sickle cell adhesion and vaso-occlusion in vivo.
R. Zennadi, B. J. Moeller, E. J. Whalen, M. Batchvarova, K. Xu, S. Shan, M. Delahunty, M. W. Dewhirst, and M. J. Telen (2007)
Blood 110, 2708-2717
   Abstract »    Full Text »    PDF »
Substrate Specificities of G Protein-Coupled Receptor Kinase-2 and -3 at Cardiac Myocyte Receptors Provide Basis for Distinct Roles in Regulation of Myocardial Function.
L. E. Vinge, K. W. Andressen, T. Attramadal, G. O. Andersen, M. S. Ahmed, K. Peppel, W. J. Koch, N. J. Freedman, F. O. Levy, T. Skomedal, et al. (2007)
Mol. Pharmacol. 72, 582-591
   Abstract »    Full Text »    PDF »
Exercise training and beta-blocker treatment ameliorate age-dependent impairment of beta-adrenergic receptor signaling and enhance cardiac responsiveness to adrenergic stimulation.
D. Leosco, G. Rengo, G. Iaccarino, A. Filippelli, A. Lymperopoulos, C. Zincarelli, F. Fortunato, L. Golino, M. Marchese, G. Esposito, et al. (2007)
Am J Physiol Heart Circ Physiol 293, H1596-H1603
   Abstract »    Full Text »    PDF »
PKC-dependent regulation of the receptor locus dominates functional consequences of cysteinyl leukotriene type 1 receptor activation.
D. A. Deshpande, R. M. Pascual, S.-W. Wang, D. M. Eckman, E. C. Riemer, C. D. Funk, and R. B. Penn (2007)
FASEB J 21, 2335-2342
   Abstract »    Full Text »    PDF »
Profiling of the renal kinome: a novel tool to identify protein kinases involved in angiotensin II-dependent hypertensive renal damage.
M. H. de Borst, S. H. Diks, J. Bolbrinker, M. W. Schellings, M. B. A. van Dalen, M. P. Peppelenbosch, R. Kreutz, Y. M. Pinto, G. Navis, and H. van Goor (2007)
Am J Physiol Renal Physiol 293, F428-F437
   Abstract »    Full Text »    PDF »
Increased expression of SERCA in the hearts of transgenic mice results in increased oxidation of glucose.
D. D. Belke, E. Swanson, J. Suarez, B. T. Scott, A. E. Stenbit, and W. H. Dillmann (2007)
Am J Physiol Heart Circ Physiol 292, H1755-H1763
   Abstract »    Full Text »    PDF »
Principles of Genetic Murine Models for Cardiac Disease.
K. E. Yutzey and J. Robbins (2007)
Circulation 115, 792-799
   Abstract »    Full Text »    PDF »
Protein Kinase A-Mediated Phosphorylation Contributes to Enhanced Contraction Observed in Mice That Overexpress beta-Adrenergic Receptor Kinase-1.
E. E. Mueller, S. A. Grandy, and S. E. Howlett (2006)
J. Pharmacol. Exp. Ther. 319, 1307-1316
   Abstract »    Full Text »    PDF »
Cardiac-Specific Ablation of G-Protein Receptor Kinase 2 Redefines Its Roles in Heart Development and {beta}-Adrenergic Signaling.
S. J. Matkovich, A. Diwan, J. L. Klanke, D. J. Hammer, Y. Marreez, A. M. Odley, E. W. Brunskill, W. J. Koch, R. J. Schwartz, and G. W. Dorn II (2006)
Circ. Res. 99, 996-1003
   Abstract »    Full Text »    PDF »
Cardiac S100A1 Protein Levels Determine Contractile Performance and Propensity Toward Heart Failure After Myocardial Infarction.
P. Most, H. Seifert, E. Gao, H. Funakoshi, M. Volkers, J. Heierhorst, A. Remppis, S. T. Pleger, B. R. DeGeorge Jr, A. D. Eckhart, et al. (2006)
Circulation 114, 1258-1268
   Abstract »    Full Text »    PDF »
Pleiotropic Phenotype of a Genomic Knock-In of an RGS-Insensitive G184S Gnai2 Allele..
X. Huang, Y. Fu, R. A. Charbeneau, T. L. Saunders, D. K. Taylor, K. D. Hankenson, M. W. Russell, L. G. D'Alecy, and R. R. Neubig (2006)
Mol. Cell. Biol. 26, 6870-6879
   Abstract »    Full Text »    PDF »
Restoration of myocardial {beta}-adrenergic receptor signaling after left ventricular assist device support.
P. K. Pandalai, C. F. Bulcao, W. H. Merrill, and S. A. Akhter (2006)
J. Thorac. Cardiovasc. Surg. 131, 975-980
   Abstract »    Full Text »    PDF »
Mechanisms of regulation of G protein-coupled receptor kinases (GRKs) and cardiovascular disease.
P. Penela, C. Murga, C. Ribas, A. S. Tutor, S. Peregrin, and F. Mayor Jr. (2006)
Cardiovasc Res 69, 46-56
   Abstract »    Full Text »    PDF »
Phospholipase C {epsilon} Modulates {beta}-Adrenergic Receptor- Dependent Cardiac Contraction and Inhibits Cardiac Hypertrophy.
H. Wang, E. A. Oestreich, N. Maekawa, T. A. Bullard, K. L. Vikstrom, R. T. Dirksen, G. G. Kelley, B. C. Blaxall, and A. V. Smrcka (2005)
Circ. Res. 97, 1305-1313
   Abstract »    Full Text »    PDF »
Proteasome degradation of GRK2 during ischemia and ventricular tachyarrhythmias in a canine model of myocardial infarction.
X. Yu, S. Huang, E. Patterson, M. W. Garrett, K. M. Kaufman, J. P. Metcalf, M. Zhu, S. T. Dunn, and D. C. Kem (2005)
Am J Physiol Heart Circ Physiol 289, H1960-H1967
   Abstract »    Full Text »    PDF »
Role of the {beta}-adrenergic receptor kinase in myocardial dysfunction after brain death.
P. K. Pandalai, J. M. Lyons, J. Y. Duffy, K. M. McLean, C. J. Wagner, W. H. Merrill, J. M. Pearl, and S. A. Akhter (2005)
J. Thorac. Cardiovasc. Surg. 130, 1183-1189
   Abstract »    Full Text »    PDF »
Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure.
G. Iaccarino, E. Barbato, E. Cipolletta, V. De Amicis, K. B. Margulies, D. Leosco, B. Trimarco, and W. J. Koch (2005)
Eur. Heart J. 26, 1752-1758
   Abstract »    Full Text »    PDF »
Upregulation of {beta}-adrenergic receptors in heart failure due to volume overload.
X. Wang, E. Sentex, H. K. Saini, D. Chapman, and N. S. Dhalla (2005)
Am J Physiol Heart Circ Physiol 289, H151-H159
   Abstract »    Full Text »    PDF »
G-protein-coupled receptor kinase activity in human heart failure: Effects of {beta}-adrenoceptor blockade.
K. Leineweber, P. Rohe, A. Beilfuss, C. Wolf, H. Sporkmann, H. Bruck, H.-G. Jakob, G. Heusch, T. Philipp, and O.-E. Brodde (2005)
Cardiovasc Res 66, 512-519
   Abstract »    Full Text »    PDF »
Targeted overexpression of G protein-coupled receptor kinase-2 in osteoblasts promotes bone loss.
L. Wang, S. Liu, L. D. Quarles, and R. F. Spurney (2005)
Am J Physiol Endocrinol Metab 288, E826-E834
   Abstract »    Full Text »    PDF »
Regulation of Cysteinyl Leukotriene Type 1 Receptor Internalization and Signaling.
S. Naik, C. K. Billington, R. M. Pascual, D. A. Deshpande, F. P. Stefano, T. A. Kohout, D. M. Eckman, J. L. Benovic, and R. B. Penn (2005)
J. Biol. Chem. 280, 8722-8732
   Abstract »    Full Text »    PDF »
Inhibition of {beta}-adrenergic receptor trafficking in adult cardiocytes by MAP4 decoration of microtubules.
G. Cheng, F. Qiao, T. N. Gallien, D. Kuppuswamy, and G. Cooper IV (2005)
Am J Physiol Heart Circ Physiol 288, H1193-H1202
   Abstract »    Full Text »    PDF »
Level of {beta}-Adrenergic Receptor Kinase 1 Inhibition Determines Degree of Cardiac Dysfunction After Chronic Pressure Overload-Induced Heart Failure.
H. Tachibana, S. V. Naga Prasad, R. J. Lefkowitz, W. J. Koch, and H. A. Rockman (2005)
Circulation 111, 591-597
   Abstract »    Full Text »    PDF »
Phosphatidylinositol 3-Kinase Offsets cAMP-Mediated Positive Inotropic Effect via Inhibiting Ca2+ Influx in Cardiomyocytes.
V. Leblais, S.-H. Jo, K. Chakir, V. Maltsev, M. Zheng, M. T. Crow, W. Wang, E. G. Lakatta, and R.-P. Xiao (2004)
Circ. Res. 95, 1183-1190
   Abstract »    Full Text »    PDF »
{beta}2 Adrenoceptor gene therapy ameliorates left ventricular dysfunction following cardiac surgery.
J. M. Jones, J. A. Petrofski, K. H. Wilson, C. Steenbergen, W. J. Koch, and C. A. Milano (2004)
Eur. J. Cardiothorac. Surg. 26, 1161-1168
   Abstract »    Full Text »    PDF »
Network integration of the adrenergic system in cardiac hypertrophy.
L. Barki-Harrington, C. Perrino, and H. A Rockman (2004)
Cardiovasc Res 63, 391-402
   Abstract »    Full Text »    PDF »
TGF-{beta}1 and angiotensin networking in cardiac remodeling.
S. Rosenkranz (2004)
Cardiovasc Res 63, 423-432
   Abstract »    Full Text »    PDF »
Altered cAMP-mediated signalling and its role in the pathogenesis of dilated cardiomyopathy.
M. A Movsesian (2004)
Cardiovasc Res 62, 450-459
   Abstract »    Full Text »    PDF »
Regulation of cardiac contractility by Rab4-modulated {beta}2-adrenergic receptor recycling.
A. Odley, H. S. Hahn, R. A. Lynch, Y. Marreez, H. Osinska, J. Robbins, and G. W. Dorn II (2004)
PNAS 101, 7082-7087
   Abstract »    Full Text »    PDF »
G Protein-Coupled Receptor Internalization Signaling Is Required for Cardioprotection in Ischemic Preconditioning.
H. Tong, H. A. Rockman, W. J. Koch, C. Steenbergen, and E. Murphy (2004)
Circ. Res. 94, 1133-1141
   Abstract »    Full Text »    PDF »
Transgenic triadin 1 overexpression alters SR Ca2+ handling and leads to a blunted contractile response to {beta}-adrenergic agonists.
U. Kirchhefer, L. R Jones, F. Begrow, P. Boknik, L. Hein, M. J Lohse, B. Riemann, W. Schmitz, J. Stypmann, and J. Neumann (2004)
Cardiovasc Res 62, 122-134
   Abstract »    Full Text »    PDF »
Right ventricular targeted gene transfer of a {beta}-adrenergic receptor kinase inhibitor improves ventricular performance after pulmonary artery banding.
S. M. Emani, A. S. Shah, M. K. Bowman, D. C. White, S. Emani, D. D. Glower, and W. J. Koch (2004)
J. Thorac. Cardiovasc. Surg. 127, 787-793
   Abstract »    Full Text »    PDF »
{beta}2-Adrenoceptor Activation Attenuates Endotoxin-Induced Acute Renal Failure.
A. Nakamura, A. Imaizumi, Y. Yanagawa, T. Kohsaka, and E. J. Johns (2004)
J. Am. Soc. Nephrol. 15, 316-325
   Abstract »    Full Text »    PDF »
Manipulating Cardiac Contractility in Heart Failure: Data From Mice and Men.
G. W. Dorn II and J. D. Molkentin (2004)
Circulation 109, 150-158
   Full Text »    PDF »
The Adrenergic Pathway and Heart Failure.
J.R. Keys and W.J. Koch (2004)
Recent Prog. Horm. Res. 59, 13-30
   Abstract »    Full Text »
Inhibitory G-proteins and their role in desensitization of the adenylyl cyclase pathway in heart failure.
A. El-Armouche, O. Zolk, T. Rau, and T. Eschenhagen (2003)
Cardiovasc Res 60, 478-487
   Abstract »    Full Text »    PDF »
What Is the Role of {beta}-Adrenergic Signaling in Heart Failure?.
M. J. Lohse, S. Engelhardt, and T. Eschenhagen (2003)
Circ. Res. 93, 896-906
   Abstract »    Full Text »    PDF »
The Third Intracellular Loop and the Carboxyl Terminus of {beta}2-Adrenergic Receptor Confer Spontaneous Activity of the Receptor.
K. Chakir, Y. Xiang, D. Yang, S.-J. Zhang, H. Cheng, B. K. Kobilka, and R.-P. Xiao (2003)
Mol. Pharmacol. 64, 1048-1058
   Abstract »    Full Text »    PDF »
Cardiac hypertrophy and altered {beta}-adrenergic signaling in transgenic mice that express the amino terminus of {beta}-ARK1.
J. R. Keys, E. A. Greene, C. J. Cooper, S. V. Naga Prasad, H. A. Rockman, and W. J. Koch (2003)
Am J Physiol Heart Circ Physiol 285, H2201-H2211
   Abstract »    Full Text »    PDF »
Differential myocardial gene expression in the development and rescue of murine heart failure.
B. C. Blaxall, R. Spang, H. A. Rockman, and W. J. Koch (2003)
Physiol Genomics 15, 105-114
   Abstract »    Full Text »    PDF »
Enhanced Gi Signaling Selectively Negates {beta}2-Adrenergic Receptor (AR)- but Not {beta}1-AR-Mediated Positive Inotropic Effect in Myocytes From Failing Rat Hearts.
R.-P. Xiao, S.-J. Zhang, K. Chakir, P. Avdonin, W. Zhu, R. A. Bond, C. W. Balke, E. G. Lakatta, and H. Cheng (2003)
Circulation 108, 1633-1639
   Abstract »    Full Text »    PDF »
Transgenic Overexpression of the Ca2+-binding Protein S100A1 in the Heart Leads to Increased in Vivo Myocardial Contractile Performance.
P. Most, A. Remppis, S. T. Pleger, E. Loffler, P. Ehlermann, J. Bernotat, C. Kleuss, J. Heierhorst, P. Ruiz, H. Witt, et al. (2003)
J. Biol. Chem. 278, 33809-33817
   Abstract »    Full Text »    PDF »
Phosphorylation of G Protein-Coupled Receptors: GPCR Kinases in Heart Disease.
J. A. Hata and W. J. Koch (2003)
Mol. Interv. 3, 264-272
   Abstract »    Full Text »    PDF »
Identification and Light-Dependent Translocation of a Cone-Specific Antigen, Cone Arrestin, Recognized by Monoclonal Antibody 7G6.
H. Zhang, N. Cuenca, T. Ivanova, J. Church-Kopish, J. M. Frederick, P. R. MacLeish, and W. Baehr (2003)
Invest. Ophthalmol. Vis. Sci. 44, 2858-2867
   Abstract »    Full Text »    PDF »
Exercise restores {beta}-adrenergic vasorelaxation in aged rat carotid arteries.
D. Leosco, G. Iaccarino, E. Cipolletta, D. De Santis, E. Pisani, V. Trimarco, N. Ferrara, P. Abete, D. Sorriento, F. Rengo, et al. (2003)
Am J Physiol Heart Circ Physiol 285, H369-H374
   Abstract »    Full Text »    PDF »
Alterations in mitochondrial function in a mouse model of hypertrophic cardiomyopathy.
D. T. Lucas, P. Aryal, L. I. Szweda, W. J. Koch, and L. A. Leinwand (2003)
Am J Physiol Heart Circ Physiol 284, H575-H583
   Abstract »    Full Text »    PDF »
Regulation of G Protein-Coupled Receptor Kinases and Arrestins During Receptor Desensitization.
T. A. Kohout and R. J. Lefkowitz (2003)
Mol. Pharmacol. 63, 9-18
   Full Text »    PDF »
Donor heart contractile dysfunction following prolonged ex vivo preservation can be prevented by gene-mediated {beta}-adrenergic signaling modulation.
H. T. Tevaearai, G. B. Walton, A. D. Eckhart, J. R. Keys, and W. J. Koch (2002)
Eur. J. Cardiothorac. Surg. 22, 733-737
   Abstract »    Full Text »    PDF »
Ischemic Protection and Myofibrillar Cardiomyopathy: Dose-Dependent Effects of In Vivo {delta}PKC Inhibition.
H. S. Hahn, M. G. Yussman, T. Toyokawa, Y. Marreez, T. J. Barrett, K. C. Hilty, H. Osinska, J. Robbins, and G. W. Dorn II (2002)
Circ. Res. 91, 741-748
   Abstract »    Full Text »    PDF »
Alterations of beta -adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta 1.
S. Rosenkranz, M. Flesch, K. Amann, C. Haeuseler, H. Kilter, U. Seeland, K.-D. Schluter, and M. Bohm (2002)
Am J Physiol Heart Circ Physiol 283, H1253-H1262
   Abstract »    Full Text »    PDF »
Phosphatidylinositol 3-Kinase Functionally Compartmentalizes the Concurrent Gs Signaling During {beta}2-Adrenergic Stimulation.
S.-H. Jo, V. Leblais, P. H. Wang, M. T. Crow, and R.-P. Xiao (2002)
Circ. Res. 91, 46-53
   Abstract »    Full Text »    PDF »
Autonomic control of blood pressure in mice: basic physiology and effects of genetic modification.
B. J. A. Janssen and J. F. M. Smits (2002)
Am J Physiol Regulatory Integrative Comp Physiol 282, R1545-R1564
   Abstract »    Full Text »    PDF »
Myocyte Redistribution of GRK2 and GRK5 in Hypertensive, Heart-Failure-Prone Rats.
X. P. Yi, A. M. Gerdes, and F. Li (2002)
Hypertension 39, 1058-1063
   Abstract »    Full Text »    PDF »
Adenoviral gene transfer to the heart during cardiopulmonary bypass: effect of myocardial protection technique on transgene expression.
J.M. Jones, K.H. Wilson, W.J. Koch, and C.A. Milano (2002)
Eur. J. Cardiothorac. Surg. 21, 847-852
   Abstract »    Full Text »    PDF »
Transgenic and knockout mouse models of atrial arrhythmias.
J. E. Olgin and S. Verheule (2002)
Cardiovasc Res 54, 280-286
   Abstract »    Full Text »    PDF »
Vascular-Targeted Overexpression of G Protein-Coupled Receptor Kinase-2 in Transgenic Mice Attenuates beta -Adrenergic Receptor Signaling and Increases Resting Blood Pressure.
A. D. Eckhart, T. Ozaki, H. Tevaearai, H. A. Rockman, and W. J. Koch (2002)
Mol. Pharmacol. 61, 749-758
   Abstract »    Full Text »    PDF »
Impaired parasympathetic heart rate control in mice with a reduction of functional G protein beta gamma -subunits.
J. Gehrmann, M. Meister, C. T. Maguire, D. C. Martins, P. E. Hammer, E. J. Neer, C. I. Berul, and U. Mende (2002)
Am J Physiol Heart Circ Physiol 282, H445-H456
   Abstract »    Full Text »    PDF »
Myocardial distribution and regulation of GRK and beta -arrestin isoforms in congestive heart failure in rats.
L. E. Vinge, E. Oie, Y. Andersson, H. K. Grogaard, G. O. Andersen, and H. Attramadal (2001)
Am J Physiol Heart Circ Physiol 281, H2490-H2499
   Abstract »    Full Text »    PDF »
Receptor Number and Caveolar Co-localization Determine Receptor Coupling Efficiency to Adenylyl Cyclase.
R. S. Ostrom, C. Gregorian, R. M. Drenan, Y. Xiang, J. W. Regan, and P. A. Insel (2001)
J. Biol. Chem. 276, 42063-42069
   Abstract »    Full Text »    PDF »
Ventricular Dysfunction After Cardioplegic Arrest Is Improved After Myocardial Gene Transfer of a {beta}-Adrenergic Receptor Kinase Inhibitor.
H. T. Tevaearai, A. D. Eckhart, K. F. Shotwell, K. Wilson, and W. J. Koch (2001)
Circulation 104, 2069-2074
   Abstract »    Full Text »    PDF »
Transgenic Studies of Cardiac Adrenergic Receptor Regulation.
A. D. Eckhart and W. J. Koch (2001)
J. Pharmacol. Exp. Ther. 299, 1-5
   Abstract »    Full Text »    PDF »
Prospective crossover comparison of carvedilol and metoprolol in patients with chronic heart failure.
C. Maack, T. Elter, G. Nickenig, K. LaRosee, M. Crivaro, A. Stablein, H. Wuttke, and M. Bohm (2001)
J. Am. Coll. Cardiol. 38, 939-946
   Abstract »    Full Text »    PDF »
Regulation of myocardial {beta}ARK1 expression in catecholamine-induced cardiac hypertrophy in transgenic mice overexpressing {alpha}1B-adrenergic receptors.
G. Iaccarino, J. R. Keys, A. Rapacciuolo, K. F. Shotwell, R. J. Lefkowitz, H. A. Rockman, and W. J. Koch (2001)
J. Am. Coll. Cardiol. 38, 534-540
   Abstract »    Full Text »    PDF »
Deletion of neutral endopeptidase exacerbates intestinal inflammation induced by Clostridium difficile toxin A.
K. S. Kirkwood, N. W. Bunnett, J. Maa, I. Castagliolo, B. Liu, N. Gerard, J. Zacks, C. Pothoulakis, and E. F. Grady (2001)
Am J Physiol Gastrointest Liver Physiol 281, G544-G551
   Abstract »    Full Text »    PDF »
Cardiac {beta}ARK1 Upregulation Induced by Chronic Salt Deprivation in Rats.
G. Iaccarino, E. Barbato, E. Cipolleta, A. Esposito, A. Fiorillo, W. J. Koch, and B. Trimarco (2001)
Hypertension 38, 255-260
   Abstract »    Full Text »    PDF »
Cardiac Gene Delivery With Cardiopulmonary Bypass.
M. J. Davidson, J. M. Jones, S. M. Emani, K. H. Wilson, J. Jaggers, W. J. Koch, and C. A. Milano (2001)
Circulation 104, 131-133
   Abstract »    Full Text »    PDF »
Sympathoadrenergic mechanisms in functional regulation and development of cardiac hypertrophy and failure: findings from genetically engineered mice.
X.-J. Du (2001)
Cardiovasc Res 50, 443-453
   Full Text »    PDF »
Cardiac remodeling after myocardial infarction is impaired in IGF-1 deficient mice.
M. Palmen, M.J.A.P. Daemen, R. Bronsaer, W.R.M. Dassen, H.R. Zandbergen, M. Kockx, J.F.M. Smits, R. van der Zee, and P.A. Doevendans (2001)
Cardiovasc Res 50, 516-524
   Abstract »    Full Text »    PDF »
Concomitant Increase of G Protein-Coupled Receptor Kinase Activity and Uncoupling of {beta}-Adrenergic Receptors in Rat Myometrium at Parturition.
V. Simon, S. Mhaouty-Kodja, C. Legrand, and J. Cohen-Tannoudji (2001)
Endocrinology 142, 1899-1905
   Abstract »    Full Text »
Stimulating G Protein-Coupled Receptors : Cure or Cause for Heart Failure?.
D. E. Vatner (2001)
Circ. Res. 88, 645-647
   Full Text »    PDF »
Myocardial function in hearts with transgenic overexpression of the G protein-coupled receptor kinase 5.
E. P. Chen, H. B. Bittner, S. A. Akhter, W. J. Koch, and R. D. Davis (2001)
Ann. Thorac. Surg. 71, 1320-1324
   Abstract »    Full Text »    PDF »
To Cre or Not To Cre : The Next Generation of Mouse Models of Human Cardiac Diseases.
K. R. Chien (2001)
Circ. Res. 88, 546-549
   Full Text »    PDF »
Cardiac Overexpression of a Gq Inhibitor Blocks Induction of Extracellular Signal-Regulated Kinase and c-Jun NH2-Terminal Kinase Activity in In Vivo Pressure Overload.
G. Esposito, S. V. N. Prasad, A. Rapacciuolo, L. Mao, W. J. Koch, and H. A. Rockman (2001)
Circulation 103, 1453-1458
   Abstract »    Full Text »    PDF »
Effect of Hypothyroidism on G Protein-Coupled Receptor Kinase 2 Expression Levels in Rat Liver, Lung, and Heart.
P. Penela, M. Barradas, M. Alvarez-Dolado, A. Munoz, and F. Mayor Jr. (2001)
Endocrinology 142, 987-991
   Abstract »    Full Text »    PDF »
Evolving Concepts in G Protein-Coupled Receptor Endocytosis: The Role in Receptor Desensitization and Signaling.
S. S. G. Ferguson (2001)
Pharmacol. Rev. 53, 1-24
   Abstract »    Full Text »    PDF »
Upregulation of G protein-linked receptor kinases with advancing age in rat aorta.
W. E. Schutzer, J. F. Reed, M. Bliziotes, and S. L. Mader (2001)